In our study, pyridostigmine inhibited the expression of CaN, NFAT3, p‐GATA4 and STIM1, prevented Orai1/STIM1 complex formation and attenuated cardiac hypertrophy. The gene discussed is NFATC4; the disease is cardiac hypertrophy.